https://www.managedhealthcareexecutive.com/view/optum-rx-removes-reauthorizations-from-an-additional-40-drugs
Beginning in January 2026, Optum Rx is removing reauthorizations for two new drug classes: hormone therapies and knee osteoarthritis injectables.
Beginning Jan. 1, 2026, Optum Rx, the...